Neoadjuvant PD-1 Monoclonal Antibody Plus Cisplatin-based Chemotherapy in Locally Advanced Upper Tract Urothelial Carcinoma

Clinical trial NCT04672317 · UNKNOWN

Trial details

NCT number: NCT04672317
Sponsor: RenJi Hospital
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Neoadjuvant Therapy of Locally Advanced Upper Urinary Tract Urothelial Carcinoma

Start date: 2020-12-10
Primary completion: 2022-06-01
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.